Meridian Bioscience

360Dx Top 30 Drops 11 Percent in April, Following Broader Market Trends

Meridian Bioscience Preliminary Fiscal Q2 Revenues Rise by up to 33 Percent

360Dx Top 30 Remains Essentially Flat in February

Magellan Diagnostics Resumes Distribution of Meridian LeadCare II Kits After Recall

Meridian Bioscience Fiscal Q1 Revenues Decline 5 Percent

360Dx Top 30 Plummets 17 Percent in January

Meridian Bioscience Gets Additional $2.5M NIH Award to Develop Revogene Respiratory Panel

Thermo Fisher Scientific, Diazyme Laboratories, Rheonix, Others Obtain FDA Clearances in December

Meridian Bioscience Campylobacter Assay Receives FDA Clearance

Meridian Biosciences SARS-CoV-2 Molecular Test May Fail With Omicron Variant, FDA Says

Meridian Bioscience Q4 Revenues Climb 19 Percent

Meridian Bioscience Nabs FDA EUA for Revogene SARS-CoV-2 Test

Meridian Bioscience Expands Recall of Blood Lead Tests

Meridian LeadCare Business Undergoes FDA Inspection, Product Recall

In Brief This Week: Meridian Bioscience, Veracyte, Amazon, Paige, Quotient, and More

Meridian Bioscience Fiscal Q3 Revenues Drop 25 Percent

Meridian Bioscience Acquires Otsuka America Pharmaceutical BreathTek Business for $20M

Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent